Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P2 receptors meet the immune system

F Di Virgilio1, P A Borea, P Illes

  • 1Department of Experimental and Diagnostic Medicine, Section of General Pathology, University of Ferrara, Via Borsari 46, I-44100, Ferrara, Italy. fdv@dns,unife.it

Trends in Pharmacological Sciences
|March 23, 2001
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In memoriam - Francesco di Virgilio: P2X7 receptors in purinergic pathophysiology.

Current opinion in pharmacology·2025
Same author

Astrocytes and major depression: The purinergic avenue.

Neuropharmacology·2022
Same author

Comparison of the incidence of intra-operative haemorrhage from ovarian vessels during ovariectomy and ovariohysterectomy of dogs and cats performed by inexperienced surgeons using surgeon's and constrictor knots.

New Zealand veterinary journal·2021
Same author

How to classify the covid-19 phenotype: a response from <i>"the first soldier in the first trench"</i> in Lombardy, north-western Italy.

Journal of biological regulators and homeostatic agents·2021
Same author

Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines.

Journal of biological regulators and homeostatic agents·2019
Same author

ATP in the tumour microenvironment drives expression of nfP2X<sub>7</sub>, a key mediator of cancer cell survival.

Oncogene·2018